DR info

臨床試験数 : 13 / 薬物数 : 21 - (DrugBank : 11) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 103

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Bupivacaine Injection
   Vanderbilt University Medical Center
      2019   -   NCT04036305   United States;
Celiprolol
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 4   NCT00190411   France;
Control
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 4   NCT00190411   France;
Irbesartan
   Assistance Publique - Hôpitaux de Paris
      2016   Phase 3   NCT02597361   France;
Kera-X
   Hadassah Medical Organization
      2008   -   NCT01307527   Israel;
Lidocaine Injection
   Vanderbilt University Medical Center
      2019   -   NCT04036305   United States;
Mecasermin
   Bispebjerg Hospital
      2011   -   NCT01446783   Denmark;
Mind-body therapy
   National Human Genome Research Institute (NHGRI)
      2000   Phase 2   NCT00001966   United States;
Oxygen
   Hospital St. Joseph, Marseille, France
      2021   Phase 4   NCT04890431   -
Riboflavin
   Hadassah Medical Organization
      2008   -   NCT01307527   Israel;
Saline
   Bispebjerg Hospital
      2011   -   NCT01446783   Denmark;
Sodium Chloride Injection
   Vanderbilt University Medical Center
      2019   -   NCT04036305   United States;